{"id":604472,"date":"2025-12-01T02:42:11","date_gmt":"2025-12-01T02:42:11","guid":{"rendered":"https:\/\/www.europesays.com\/uk\/604472\/"},"modified":"2025-12-01T02:42:11","modified_gmt":"2025-12-01T02:42:11","slug":"telehealth-start-up-eucalyptus-doubles-revenues-on-strong-uk-demand-for-its-weight-loss-drugs","status":"publish","type":"post","link":"https:\/\/www.europesays.com\/uk\/604472\/","title":{"rendered":"Telehealth start-up Eucalyptus doubles revenues on strong UK demand for its weight-loss drugs"},"content":{"rendered":"<p>Woolworths-backed telehealth start-up Eucalyptus has doubled its annual revenue to almost $250 million as sales of GLP-1 weight loss drugs boomed across Australia and the United Kingdom.<\/p>\n<p>The Sydney-headquartered company, which began life as a collection of consumer retail brands in 2018, has become Australia\u2019s largest online weight-loss medication company thanks to the success of its two brands, Pilot and Juniper.<\/p>\n<p>Loading&#8230;<\/p>\n","protected":false},"excerpt":{"rendered":"Woolworths-backed telehealth start-up Eucalyptus has doubled its annual revenue to almost $250 million as sales of GLP-1 weight&hellip;\n","protected":false},"author":2,"featured_media":604473,"comment_status":"","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[3,4],"tags":[748,393,4884,1144,712,16,15,1764],"class_list":{"0":"post-604472","1":"post","2":"type-post","3":"status-publish","4":"format-standard","5":"has-post-thumbnail","7":"category-uk","8":"category-united-kingdom","9":"tag-britain","10":"tag-england","11":"tag-great-britain","12":"tag-northern-ireland","13":"tag-scotland","14":"tag-uk","15":"tag-united-kingdom","16":"tag-wales"},"share_on_mastodon":{"url":"https:\/\/pubeurope.com\/@uk\/115642010520074549","error":""},"_links":{"self":[{"href":"https:\/\/www.europesays.com\/uk\/wp-json\/wp\/v2\/posts\/604472","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.europesays.com\/uk\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.europesays.com\/uk\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/uk\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/uk\/wp-json\/wp\/v2\/comments?post=604472"}],"version-history":[{"count":0,"href":"https:\/\/www.europesays.com\/uk\/wp-json\/wp\/v2\/posts\/604472\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/uk\/wp-json\/wp\/v2\/media\/604473"}],"wp:attachment":[{"href":"https:\/\/www.europesays.com\/uk\/wp-json\/wp\/v2\/media?parent=604472"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.europesays.com\/uk\/wp-json\/wp\/v2\/categories?post=604472"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.europesays.com\/uk\/wp-json\/wp\/v2\/tags?post=604472"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}